Post-approval studies (Phase 4)Study completedNCT00238472
What this trial is testing
A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 24